AllorecognitionThe response to histoincompatible tissues was designated as allorecognition. Histocompatibility antigens can be recognized by (allo)antibodies and by T cells. The strongest alloreaction is directed against incompatible molecules encoded by the Major Histocompatibility Complex (MHC). This can be explained by the fact that these MHC molecules play a fundamental role in antigen presentation and are thus optimally shaped to be recognized by T cells. Furthermore, they are extremely polymorphic so that two individuals virtually always express a different set of MHC molecules. Allorecognition at the basis of a rejection of an organ have many points in common with the allorecognition causing GVHD. The response is initiated by the stimulator APC expressing the alloantigens will prime the responder T cells. These T cells may attack the stimulator directly or help B cells to produce MHC-specific antibodies. Hence, whether the organ is rejected by alloantibodies or by cytotoxic T cells or whether the HSC transplanted patient is attacked by the donor T cells (GVHD), the response starts always with the activation of allogeneic T cells.
The strongest alloreaction is directed against incompatible molecules encoded by the Major Histocompatibility Complex (MHC). This can be explained by the fact that these MHC molecules play a fundamental role in antigen presentation and are thus optimally shaped to be recognized by T cells.
Furthermore, they are extremely polymorphic so that two individuals virtually always express a different set of MHC molecules. Three types of immune cells play a essential role in allorecognition:
But even when the donor and the recipient express the same MHC molecules, the T cell may recognize minor histocompatibilty antigens that are different between donor and recipient. |